20102019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2010

(18)FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: An economic evaluation

van Loon, J., Grutters, J. P. C., Wanders, R., Boersma, L., Dingemans, A-M. C., Bootsma, G., Geraedts, W., Pitz, C., Simons, J. P., Brans, B., Snoep, G., Hochstenbag, M., Lambin, P. & De Ruysscher, D., Jan 2010, In : European Journal of Cancer. 46, 1, p. 110-119

Research output: Contribution to journalArticleAcademicpeer-review

A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer

Lind, J. S., Dingemans, A. M., Groen, H. J., Thunnissen, F. B., Bekers, O., Heideman, D. A., Honeywell, R. J., Giovannetti, E., Peters, G. J., Postmus, P. E., van Suylen, R. J. & Smit, E. F., 1 Jun 2010, In : Clinical Cancer Research. 16, 11, p. 3078-3087 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

62 Citations (Scopus)

Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients

Dehing-Oberije, C., De Ruysscher, D., Petit, S., Van Meerbeeck, J., Vandecasteele, K., De Neve, W., Dingemans, A. M. C., El Naqa, I., Deasy, J. O., Bradley, J., Huang, E. & Lambin, P., Dec 2010, In : Radiotherapy and Oncology. 97, 3, p. 455-461

Research output: Contribution to journalArticleAcademicpeer-review

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

Lind, J. S. W., Meijerink, M. R., Dingemans, A-M. C., van Kuijk, C., Ollers, M. C., de Ruysscher, D., Postmus, P. E. & Smit, E. F., Dec 2010, In : European Radiology. 20, 12, p. 2890-2898

Research output: Contribution to journalArticleAcademicpeer-review

Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer

Dingemans, A-M. C., van den Boogaart, V., Vosse, B. A., van Suylen, R-J., Griffioen, A. W. & Thijssen, V. L., 17 Jun 2010, In : Molecular Cancer. 9, p. 9

Research output: Contribution to journalArticleAcademicpeer-review

Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non-Small-Cell Lung Cancer

van Baardwijk, A., Wanders, S., Boersma, L., Borger, J., Oellers, M., Dingemans, A-M. C., Bootsma, G., Geraedts, W., Pitz, C., Lunde, R., Lambin, P. & De Ruysscher, D., 10 Mar 2010, In : Journal of Clinical Oncology. 28, 8, p. 1380-1386

Research output: Contribution to journalArticleAcademicpeer-review

PET imaging of hypoxia using [F-18]HX4: a phase I trial

van Loon, J., Janssen, M. H. M., Ollers, M., Aerts, H. J. W. L., Dubois, L., Hochstenbag, M., Dingemans, A-M. C., Lalisang, R., Brans, B., Windhorst, B., van Dongen, G. A. M. S., Kolb, H., Zhang, J., De Ruysscher, D. & Lambin, P., Aug 2010, In : European Journal of Nuclear Medicine and Molecular Imaging. 37, 9, p. 1663-1668

Research output: Contribution to journalArticleAcademicpeer-review

Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study

van Loon, J., De Ruysscher, D., Wanders, R., Boersma, L., Simons, J. P., Oellers, M., Dingemans, A-M. C., Hochstenbag, M., Bootsma, G., Geraedts, W., Pitz, C., Teule, J., Rhami, A., Thimister, W., Snoep, G., Dehing-Oberije, C. & Lambin, P., 1 Jun 2010, In : International Journal of Radiation Oncology Biology Physics. 77, 2, p. 329-36 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report

Smit, E. F., Dingemans, A. M., Thunnissen, F. B., Hochstenbach, M. M., van Suylen, R. J. & Postmus, P. E., May 2010, In : Journal of Thoracic Oncology. 5, 5, p. 719-720 2 p.

Research output: Contribution to journalArticleAcademicpeer-review

25 Citations (Scopus)

Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome

Swarts, D. R. A., Claessen, S. M. H., Jonkers, Y. M. H., van Suylen, R-J., Dingemans, A-M. C., de Herder, W. W., de Krijger, R. R., Smit, E. F., Thunnissen, F. B. J. M., Seldenrijk, C. A., Vink, A., Perren, A., Ramaekers, F. C. S. & Speel, E-J. M., Sep 2011, In : American Journal of Pathology. 179, 3, p. 1129-1137 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: A hypothesis generating study

van Loon, J., Offermann, C., Ollers, M., van Elmpt, W., Vegt, E., Rahmy, A., Dingemans, A-M. C., Lambin, P. & De Ruysscher, D., May 2011, In : Radiotherapy and Oncology. 99, 2, p. 172-175

Research output: Contribution to journalArticleAcademicpeer-review

First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

Dingemans, A. -M. C., de Langen, A. J., van den Boogaart, V., Marcus, J. T., Backes, W. H., Scholtens, H. T. G. M., van Tinteren, H., Hoekstra, O. S., Pruim, J., Brans, B., Thunnissen, F. B., Smit, E. F. & Groen, H. J. M., Mar 2011, In : Annals of Oncology. 22, 3, p. 559-566

Research output: Contribution to journalArticleAcademicpeer-review

Low molecular weight heparins in the treatment of lung cancer

Mellema, W. W., Smit, E. F. & Dingemans, A-M. C., Nov 2011, In : Expert Opinion on Investigational Drugs. 20, 11, p. 1517-1522

Research output: Contribution to journalArticleAcademicpeer-review

MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer

Lee, J-H., Voortman, J., Dingemans, A-M. C., Voeller, D. M., Pham, T., Wang, Y. & Giaccone, G., 22 Jun 2011, In : PLOS ONE. 6, 6, p. 8

Research output: Contribution to journalArticleAcademicpeer-review

Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI

de Langen, A. J., van den Boogaart, V., Lubberink, M., Backes, W. H., Marcus, J. T., van Tinteren, H., Pruim, J., Brans, B., Leffers, P., Dingemans, A-M. C., Smit, E. F., Groen, H. J. M. & Hoekstra, O. S., 1 Jan 2011, In : Journal of Nuclear Medicine. 52, 1, p. 48-55

Research output: Contribution to journalArticleAcademicpeer-review

Primary Ewing's sarcoma presenting as a Pancoast tumour

Vanfleteren, L., van Stiphout, R., Riedl, R. G., Jansen, R., de Ruysscher, D. & Dingemans, A. M., 1 Jan 2011, In : Thorax. 66, 1, p. 89-90

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062

O'Brien, M. E. R., Konopa, K., Lorigan, P., Bosquee, L., Marshall, E., Bustin, F., Margerit, S., Fink, C., Stigt, J. A., Dingemans, A. M. C., Hasan, B., Van Meerbeeck, J. & Baas, P., Oct 2011, In : European Journal of Cancer. 47, 15, p. 2322-2330

Research output: Contribution to journalArticleAcademicpeer-review

Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: A prospective population-based study

Wanders, R., Steevens, J., Botterweck, A., Dingemans, A-M. C., Reymen, B., van Baardwijk, A., Borger, J., Bootsma, G., Pitz, C., Lunde, R., Geraedts, W., Lambin, P. & De Ruysscher, D., Dec 2011, In : European Journal of Cancer. 47, 18, p. 2691-2697

Research output: Contribution to journalArticleAcademicpeer-review

2012

A role of active brown adipose tissue in cancer cachexia?

Beijer, E., Schoenmakers, J., Vijgen, G., Kessels, F., Dingemans, A. M., Schrauwen, P., Wouters, E., van Marken Lichtenbelt, W., Teule, J. & Brans, B., 1 Jan 2012, In : Oncology Reviews. 6, 1, p. 88-94

Research output: Contribution to journalArticleAcademic

2 Citations (Scopus)

Estimating quality adjusted progression free survival of first-line treatments for EGFR mutation positive non small cell lung cancer patients in The Netherlands

Verduyn, S. C., Biesma, B., Schramel, F. M. N. H., van der Scheer, F. W., Langenfeld, M. K., de Peuter, M. A. & Dingemans, A-M. C., 10 Sep 2012, In : Health and Quality of Life Outcomes. 10, p. 108

Research output: Contribution to journalArticleAcademicpeer-review

Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study

De Ruysscher, D., van Baardwijk, A., Steevens, J., Botterweck, A., Bosmans, G., Reymen, B., Wanders, R., Borger, J., Dingemans, A-M. C., Bootsma, G., Pitz, C., Lunde, R., Geraedts, W., Oellers, M., Dekker, A. & Lambin, P., Feb 2012, In : Radiotherapy and Oncology. 102, 2, p. 228-233

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Scopus)

Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer

van Baardwijk, A., Reymen, B., Wanders, S., Borger, J., Ollers, M., Dingemans, A-M. C., Bootsma, G., Geraedts, W., Pitz, C., Lunde, R., Peters, F., Lambin, P. & De Ruysscher, D., Oct 2012, In : European Journal of Cancer. 48, 15, p. 2339-2346

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Scopus)

Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?

De Ruysscher, D., Van Meerbeeck, J., Vandecasteele, K., Oberije, C., Pijls, M., Dingemans, A. M. C., Reymen, B., van Baardwijk, A., Wanders, R., Lammering, G., Lambin, P. & De Neve, W., Jul 2012, In : Strahlentherapie Und onkologie. 188, 7, p. 564-567

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)

Radical Treatment of Non-Small-Cell Lung Cancer Patients with Synchronous Oligometastases Long-Term Results of a Prospective Phase II Trial (Nct01282450)

De Ruysscher, D., Wanders, R., van Baardwijk, A., Dingemans, A-M. C., Reymen, B., Houben, R., Bootsma, G., Pitz, C., van Eijsden, L., Geraedts, W., Baumert, B. G. & Lambin, P., Oct 2012, In : Journal of Thoracic Oncology. 7, 10, p. 1547-1555

Research output: Contribution to journalArticleAcademicpeer-review

83 Citations (Scopus)

Response Assessment Using F-18-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non-Small Cell Lung Cancer

van Elmpt, W., Ollers, M., Dingemans, A-M. C., Lambin, P. & De Ruysscher, D., Oct 2012, In : Journal of Nuclear Medicine. 53, 10, p. 1514-1520

Research output: Contribution to journalArticleAcademicpeer-review

VeriStrat (R) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib

Kuiper, J. L., Lind, J. S. W., Groen, H. J. M., Roder, J., Grigorieva, J., Roder, H., Dingemans, A. M. C. & Smit, E. F., 20 Nov 2012, In : British Journal of Cancer. 107, 11, p. 1820-1825

Research output: Contribution to journalArticleAcademicpeer-review

23 Citations (Scopus)
2013

A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non-Small Cell Lung Cancer with a KRAS Mutation

Dingemans, A-M. C., Mellema, W. W., Groen, H. J. M., van Wijk, A., Burgers, S. A., Kunst, P. W. A., Thunnissen, E., Heideman, D. A. M. & Smit, E. F., 1 Feb 2013, In : Clinical Cancer Research. 19, 3, p. 743-751

Research output: Contribution to journalArticleAcademicpeer-review

43 Citations (Scopus)

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study(dagger)

Aerts, J. G., Codrington, H., Lankheet, N. A. G., Burgers, S., Biesma, B., Dingemans, A. -M. C., Vincent, A. D., Dalesio, O., Groen, H. J. M. & Smit, E. F., Nov 2013, In : Annals of Oncology. 24, 11, p. 2860-2865

Research output: Contribution to journalArticleAcademicpeer-review

31 Citations (Scopus)

Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients

Heuvers, M. E., Muskens, F., Bezemer, K., Lambers, M., Dingemans, A-M. C., Groen, H. J. M., Smit, E. F., Hoogsteden, H. C., Hegmans, J. P. J. J. & Aerts, J. G. J. V., Sep 2013, In : Lung Cancer. 81, 3, p. 468-474

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)

Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients

Nalbantov, G., Kietselaer, B., Vandecasteele, K., Oberije, C., Berbee, M., Troost, E., Dingemans, A. M., Baardwijk, A. V., Smits, K., Dekker, A., Bussink, J., Ruysscher, D. D., Lievens, Y. & Lambin, P., Oct 2013, In : Radiotherapy and Oncology. 109, 1, p. 100-106 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Scopus)

CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids

Swarts, D. R. A., Henfling, M. E. R., Van Neste, L., van Suylen, R-J., Dingemans, A-M. C., Dinjens, W. N. M., Haesevoets, A., Rudelius, M., Thunnissen, E., Volante, M., Van Criekinge, W., van Engeland, M., Ramaekers, F. C. S. & Speel, E-J. M., 15 Apr 2013, In : Clinical Cancer Research. 19, 8, p. 2197-2207

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)

KRAS Mutations in Advanced Nonsquamous Non-Small-Cell Lung Cancer Patients Treated with First-Line Platinum-Based Chemotherapy Have No Predictive Value

Mellema, W. W., Dingemans, A-M. C., Thunnissen, E., Snijders, P. J. F., Derks, J., Heideman, D. A. M., Van Suylen, R. & Smit, E. F., Sep 2013, In : Journal of Thoracic Oncology. 8, 9, p. 1190-1195

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)

Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia.

Op den Kamp, C. M. H., Langen, R. C. J., Snepvangers, F. J., de Theije, C. C., Schellekens, J. M., Laugs, F., Dingemans, A. M. & Schols, A. M. W. J., Sep 2013, In : American Journal of Clinical Nutrition. 98, 3, p. 738-748 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

47 Citations (Scopus)

Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?

Hendriks, L. E. L. ., Bootsma, G. P., de Ruysscher, D. K. M., Scheppers, N. A. M., Hofmane, P. A. M., Brans, B. T. & Dingemans, A-M. C., Jun 2013, In : Lung Cancer. 80, 3, p. 293-297

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)

Total Gross Tumor Volume Is an Independent Prognostic Factor in Patients Treated With Selective Nodal Irradiation for Stage I to III Small Cell Lung Cancer

Reymen, B., Van Loon, J., van Baardwijk, A., Wanders, R., Borger, J., Dingemans, A-M. C., Bootsma, G., Pitz, C., Lunde, R., Geraedts, W., Lambin, P. & De Ruysscher, D., 1 Apr 2013, In : International Journal of Radiation Oncology Biology Physics. 85, 5, p. 1319-1324

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Scopus)

VeriStrat (R) has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: Pooled analysis of SAKK19/05 and NTR528

Gautschi, O., Dingemans, A-M., Crowe, S., Peters, S., Roder, H., Grigorieva, J., Roder, J., Zappa, F., Pless, M., Brutsche, M., Baty, F., Bubendorf, L., Schmitz, S-F. H., Na, K-J., Carbone, D., Stahel, R. & Smit, E., Jan 2013, In : Lung Cancer. 79, 1, p. 59-64

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)
2014

8 Years' experience with robotic thymectomy for thymomas

Keijzers, M., Dingemans, A-M. C., Blaauwgeers, H., van Suylen, R. J., Hochstenbag, M., van Garsse, L., Accord, R., de Baets, M. & Maessen, J., Apr 2014, In : Surgical endoscopy and other interventional techniques. 28, 4, p. 1202-1208

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)

A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin-Vinorelbine-Cetuximab in Patients With Stage III Non-Small-Cell Lung Cancer

Dingemans, A-M. C., Bootsma, G., van Baardwijk, A., Reymen, B., Wanders, R., Brans, B., Das, M., Hochstenbag, M., van Belle, A., Houben, R., Lambin, P. & de Ruysscher, D., May 2014, In : Journal of Thoracic Oncology. 9, 5, p. 710-716

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)

A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: A step toward individualized care and shared decision making

Oberije, C., Nalbantov, G., Dekker, A., Boersma, L., Borger, J., Reymen, B., van Baardwijk, A., Wanders, R., De Ruysscher, D., Steyerberg, E., Dingemans, A-M. & Lambin, P., Jul 2014, In : Radiotherapy and Oncology. 112, 1, p. 37-43

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)

Early body weight loss during concurrent chemo-radiotherapy for non-small cell lung cancer

Op den Kamp, C. M. H., de Ruysscher, D. K. M., van den Heuvel, M., Elferink, M., Houben, R. M. A., Oberije, C. J. G., Bootsma, G. P., Geraedts, W. H., Pitz, C. C. M., Langen, R. C., Wouters, E. F. M., Schols, A. M. W. J. & Dingemans, A. M. C., 1 Jan 2014, In : Journal of cachexia, sarcopenia and muscle. 5, 2, p. 127-137

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)

EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?

Hendriks, L. E. L., Smit, E. F., Vosse, B. A. H., Mellema, W. W., Heideman, D. A. M., Bootsma, G. P., Westenend, M., Pitz, C., de Vries, G. J., Houben, R., Grunberg, K., Bendek, M., Speel, E-J. M. & Dingemans, A-M. C., Apr 2014, In : Lung Cancer. 84, 1, p. 86-91

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Scopus)

Galectin Expression Profiling Identifies Galectin-1 and Galectin-9 Delta 5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer

Schulkens, I. A., Heusschen, R., van den Boogaart, V., van Suylen, R-J., Dingemans, A-M. C., Griffioen, A. W. & Thijssen, V. L., 26 Sep 2014, In : PLOS ONE. 9, 9, e107988.

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)

Interobserver Variability for the WHO Classification of Pulmonary Carcinoids

Swarts, D. R. A., van Suylen, R-J., den Bakker, M. A., van Oosterhout, M. F. M., Thunnissen, F. B. J. M., Volante, M., Dingemans, A-M. C., Scheltinga, M. R. M., Bootsma, G. P., Pouwels, H. M. M., van den Borne, B. E. E. M., Ramaekers, F. C. S. & Speel, E-J. M., Oct 2014, In : American Journal of Surgical Pathology. 38, 10, p. 1429-1436

Research output: Contribution to journalArticleAcademicpeer-review

Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR)

Reymen, B., van Baardwijk, A., Wanders, R., Borger, J., Dingemans, A-M. C., Bootsma, G., Pitz, C., Lunde, R., Geraedts, W., Lambin, P. & De Ruysscher, D., Mar 2014, In : Radiotherapy and Oncology. 110, 3, p. 482-487

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)

Lungscape: Resected Non-Small-Cell Lung Cancer Outcome by Clinical and Pathological Parameters

Peters, S., Weder, W., Dafni, U., Kerr, K. M., Bubendorf, L., Meldgaard, P., O'Byrne, K. J., Wrona, A., Vansteenkiste, J., Felip, E., Marchetti, A., Savic, S., Lu, S., Smit, E., Dingemans, A-M., Blackhall, F. H., Baas, P., Camps, C., Rosell, R. & Stahel, R. A., Nov 2014, In : Journal of Thoracic Oncology. 9, 11, p. 1675-1684

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)

Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases

Hendriks, L. E. L., Troost, E. G. C., Steward, A., Bootsma, G. P., De Jaeger, K., van den Borne, B. E. E. M. & Dingemans, A-M. C., Jul 2014, In : Acta Oncologica. 53, 7, p. 945-951

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Phase II drugs that are currently in development for the treatment of cachexia

Dingemans, A-M. C., de Vos-Geelen, J., Langen, R. & Schols, A. M. W., Dec 2014, In : Expert Opinion on Investigational Drugs. 23, 12, p. 1655-1669

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)

What to choose as radical local treatment for lung metastases from cob-rectal cancer: Surgery or radiofrequency ablation?

Schlijper, R. C. J., Grutters, J. P. C., Houben, R., Dingemans, A-M. C., Wildberger, J. E., Van Raemdonck, D., Van Cutsem, E., Haustermans, K., Lammering, G., Lambin, P. & De Ruysscher, D., Feb 2014, In : Cancer Treatment Reviews. 40, 1, p. 60-67

Research output: Contribution to journalArticleAcademicpeer-review

25 Citations (Scopus)